Ligand validation:3AF1

GOL: GLYCEROL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3AF1_GOL_A_325	29%	91%	0.197	0.854	0.37	0.19	-	-	0	0	100%	1
3AF1_GOL_A_319	29%	88%	0.226	0.883	0.41	0.25	-	-	1	0	100%	1
3AF1_GOL_A_321	25%	89%	0.202	0.834	0.42	0.23	-	-	0	0	100%	1
3AF1_GOL_A_318	16%	82%	0.331	0.906	0.32	0.47	-	-	3	0	100%	1
3AF1_GOL_A_326	15%	91%	0.278	0.841	0.36	0.2	-	-	0	0	100%	1
3AF1_GOL_A_327	10%	91%	0.26	0.767	0.35	0.23	-	-	0	0	100%	1
3AF1_GOL_A_329	10%	80%	0.33	0.837	0.35	0.48	-	-	0	0	100%	1
3AF1_GOL_A_324	6%	80%	0.29	0.733	0.41	0.44	-	-	0	0	100%	1
3AF1_GOL_A_322	3%	84%	0.567	0.933	0.31	0.45	-	-	0	0	100%	1
3AF1_GOL_A_320	3%	85%	0.333	0.689	0.35	0.39	-	-	0	0	100%	1
3AF1_GOL_A_323	3%	89%	0.486	0.847	0.38	0.25	-	-	0	0	100%	1
3AF1_GOL_A_328	3%	86%	0.437	0.78	0.36	0.36	-	-	2	0	100%	1
3AF1_GOL_A_330	3%	83%	0.53	0.85	0.36	0.42	-	-	0	0	100%	1
5XLV_GOL_A_423	71%	66%	0.121	0.942	0.5	0.81	-	-	2	0	100%	1
3AVQ_GOL_A_320	58%	88%	0.181	0.96	0.33	0.34	-	-	2	0	100%	1
3AF3_GOL_A_317	48%	92%	0.152	0.894	0.34	0.19	-	-	1	0	100%	1
3AF4_GOL_A_317	47%	88%	0.153	0.89	0.35	0.32	-	-	1	0	100%	1
3AF2_GOL_A_321	40%	79%	0.152	0.862	0.33	0.53	-	-	2	0	100%	1
2NT0_GOL_D_506	100%	73%	0.016	0.997	0.3	0.72	-	-	0	0	100%	1
2YOQ_GOL_A_1196	100%	35%	0.024	0.996	0.38	2.12	-	2	0	0	100%	1
3V5K_GOL_D_276	100%	96%	0.022	0.995	0.21	0.17	-	-	0	0	100%	1
4KFD_GOL_D_806	100%	57%	0.024	0.995	0.41	1.21	-	-	0	0	100%	1
4KFE_GOL_E_803	100%	63%	0.024	0.995	0.31	1.07	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.